TGA clarifies therapeutic goods are unaffected by chemical production and import ban TGA has clarified the impact of Australias industrial chemicals standards on medicines, medical devices, and biologicals
These include brief stinging during injection lasting seconds to a minute, small drop of blood at the injection site, temporary redness in a quarter-sized area around the site, slight firmness or bump at the injection location, mild warmth at the site for several hours, and faint bruising that appears over the following day
What UK Guidance Says About Unapproved Peptides NICE, the MHRA, and the NHS do not endorse CJC 1295, ipamorelin, or retatrutide
In a post-hoc analysis of the published SURPASS trials, the change in systolic blood pressure was greater for tirzepatide versus the comparators of the trials (tirzepatide 5 mg: -5.1 to -1.3 mmHg, tirzepatide 10 mg: -6.5 to -1.7 mmHg, tirzepatide 15 mg: -11.5 to -3.1 mmHg) [65]
Where To Put The GLP-1 Patches
AASLD guidance recommends considering them in patients with concurrent co-morbidities such as obesity and diabetes given their potential benefit in NAFLD